Applications of nanoparticle systems in gene delivery and gene therapy

References

• Abdallah B, Hassan A, Benoist C, Goula D, Behr JP, Demeneix BA. 1996. A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. Hum Gene Ther. 7:1947–1954.
   PubMed Web of Science ®Google Scholar
• Akiyoshi K, Kobayashi S, Shichibe S, Mix D, Baudys M, Kim SW, Sunamoto J. 1998. Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: complexation and stabilization of insulin. J Control Release. 54:313–320.
   PubMed Web of Science ®Google Scholar
• Almeida AJ, Souto E. 2007. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev. 59:478–490.
   PubMed Web of Science ®Google Scholar
• Anajwala CC, Jani GK, Swamy SV. 2010. Current trends of nanotechnology for cancer therapy. Int J Pharm Sci Nanotechnol. 3: 1043–1056.
   Google Scholar
• Bangham A, Horne R. 1964. Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope. J Mol Biol. 8:660–IN10.
   PubMed Web of Science ®Google Scholar
• Bengali Z, Pannier AK, Segura T, Anderson BC, Jang JH, Mustoe TA, Shea LD. 2005. Gene delivery through cell culture substrate adsorbed DNA complexes. Biotechnol Bioeng. 90:290–302.
   PubMed Web of Science ®Google Scholar
• Brem H, Gabikian P. 2001. Biodegradable polymer implants to treat brain tumors. J Control Release. 74:63–67.
   PubMed Web of Science ®Google Scholar
• Burke RS, Pun SH. 2008. Extracellular barriers to in vivo PEI and PEGylated PEI polyplex-mediated gene delivery to the liver. Bioconjug Chem. 19:693–704.
   PubMed Web of Science ®Google Scholar
• Caplan AI. 2005. Review: mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng. 11:1198–1211.
   PubMedGoogle Scholar
• Chen PC, Mwakwari SC, Oyelere AK. 2008. Gold nanoparticles: from nanomedicine to nanosensing. Nanotechnol Sci Appl. 1:45.
   PubMedGoogle Scholar
• Choi YH, Liu F, Choi JS, Kim SW, Park JS. 1999. Characterization of a targeted gene carrier, lactose-polyethylene glycol-grafted poly-L-lysine, and its complex with plasmid DNA. Hum Gene Ther. 10:2657–2665.
   PubMed Web of Science ®Google Scholar
• Coll JL, Chollet P, Brambilla E, Desplanques D, Behr JP, Favrot M. 1999. In vivo delivery to tumors of DNA complexed with linear polyethylenimine. Hum Gene Ther. 10:1659–1666.
   PubMed Web of Science ®Google Scholar
• Dang JM, Leong KW. 2006. Natural polymers for gene delivery and tissue engineering. Adv Drug Deliv Rev. 58:487–499.
   PubMed Web of Science ®Google Scholar
• Daniel M-C, Astruc D. 2004. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev. 104:293–346.
   PubMed Web of Science ®Google Scholar
• Eldem T, Speiser P, Hincal A. 1991. Optimization of spray-dried and-congealed lipid micropellets and characterization of their surface morphology by scanning electron microscopy. Pharm Res. 8:47–54.
   PubMed Web of Science ®Google Scholar
• Eliyahu H, Barenholz Y, Domb A. 2005. Polymers for DNA delivery. Molecules. 10:34–64.
   PubMed Web of Science ®Google Scholar
• Ensign LM, Cone R, Hanes J. 2012. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Deliv Rev. 64:557–570.
   PubMed Web of Science ®Google Scholar
• Fahr A, Liu X. 2007. Drug delivery strategies for poorly water-soluble drugs. Expert Opin Drug Deliv. 4:403–416.
   PubMed Web of Science ®Google Scholar
• Fajac I, Allo JC, Souil E, Merten M, Pichon C, Figarella C, et al. 2000. Histidylated polylysine as a synthetic vector for gene transfer into immortalized cystic fibrosis airway surface and airway gland serous cells. J Gene Med. 2:368–378.
   PubMed Web of Science ®Google Scholar
• Ferrari S, Moro E, Pettenazzo A, Behr JP, Zacchello F, Scarpa M. 1997. ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo. Gene Ther. 4:1100–1106.
   PubMed Web of Science ®Google Scholar
• Fischer M, Vögtle F. 1999. Dendrimers: from design to application—a progress report. Angew Chem Int Ed. 38:884–905.
   PubMed Web of Science ®Google Scholar
• Frechet JM. 1994. Functional polymers and dendrimers: reactivity, molecular architecture, and interfacial energy. Science. 263: 1710–1715.
   PubMed Web of Science ®Google Scholar
• Gasco MR. 1993. Method for producing solid lipid microspheres having a narrow size distribution. Google Patents.
   Google Scholar
• Ghosh P, Han G, De M, Kim CK, Rotello VM. 2008. Gold nanoparticles in delivery applications. Adv Drug Deliv Rev. 60:1307–1315.
   PubMed Web of Science ®Google Scholar
• Glover DJ, Lipps HJ, Jans DA. 2005. Towards safe, non-viral therapeutic gene expression in humans. Nat Rev Genet. 6:299–310.
   PubMed Web of Science ®Google Scholar
• Gyawali D, Palmer M, Tran RT, Yang I. 2012. for Theranostic Systems. Biomedical Materials and Diagnostic Devices, p. 435.
   Google Scholar
• Han G, Martin CT, Rotello VM. 2006. Stability of gold nanoparticle‐bound DNA toward biological, physical, and chemical agents. Chem Biol Drug Des. 67:78–82.
   PubMed Web of Science ®Google Scholar
• Han S-o, Mahato RI, Sung YK, Kim SW. 2000. Development of biomaterials for gene therapy. Mol Ther. 2:302–317.
   PubMed Web of Science ®Google Scholar
• Harada-Shiba M, Yamauchi K, Harada A, Takamisawa I, Shimokado K, Kataoka K. 2002. Polyion complex micelles as vectors in gene therapy–pharmacokinetics and in vivo gene transfer. Gene Ther. 9:407–414.
   PubMed Web of Science ®Google Scholar
• Hawker CJ, Frechet JM. 1992. Unusual macromolecular architectures: The convergent growth approach to dendritic polyesters and novel block copolymers. J Am Chem Soc. 114:8405–8413.
   Web of Science ®Google Scholar
• Jeong JH, Kim SW, Park TG. 2007. Molecular design of functional polymers for gene therapy. Prog Polym Sci. 32:1239–1274.
   Web of Science ®Google Scholar
• Jin R, Wu G, Li Z, Mirkin CA, Schatz GC. 2003. What controls the melting properties of DNA-linked gold nanoparticle assemblies? J Am Chem Soc. 125:1643–1654.
   PubMed Web of Science ®Google Scholar
• Jin S, Leach JC, Ye K. 2009. Nanoparticle-mediated gene delivery In: Lee IW, Foote RS, Eds. Micro and Nano Technologies in Bioanalysis. Berlin: Springer, pp. 547–557.
   Google Scholar
• Jores K, Haberland A, Wartewig S, Mäder K, Mehnert W. 2005. Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorometry and Raman spectroscopy. Pharm Res. 22: 1887–1897.
   PubMed Web of Science ®Google Scholar
• Junghans M, Kreuter J, Zimmer A. 2000. Antisense delivery using protamine–oligonucleotide particles. Nucleic Acids Res. 28: e45–e45.
   PubMedGoogle Scholar
• Kakkar V, Singh S, Singla D, Kaur IP. 2011. Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin. Mol Nutr Food Res. 55:495–503.
   PubMed Web of Science ®Google Scholar
• Kasyanenko N, Lysyakova LA, Dribinskii BA, Zolotova YuI, Nazarova OV, Panarin EF. 2012. DNA-polymer complexes for gene therapy. Polym Sci Ser C. 54:57–68.
   Web of Science ®Google Scholar
• Kaul G, Amiji M. 2005. Cellular interactions and in vitro DNA transfection studies with poly (ethylene glycol)‐modified gelatin nanoparticles. J Pharm Sci. 94:184–198.
   PubMed Web of Science ®Google Scholar
• Kaul G. 2005. Amiji M. Tumor-targeted gene delivery using poly (ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies. Pharm Res. 22:951–961.
   Google Scholar
• Kievit FM, Veiseh O, Bhattarai N, Fang C, Gunn JW, Lee D, et al. 2009. PEI–PEG–chitosan‐copolymer‐coated iron oxide nanoparticles for safe gene delivery: synthesis, complexation, and transfection. Adv Funct Mater. 19:2244–2251.
   PubMed Web of Science ®Google Scholar
• Kim WJ, Yockman JW, Lee M, Jeong JH, Kim YH, Kim SW. 2005. Soluble Flt-1 gene delivery using PEI- g-PEG-RGD conjugate for anti-angiogenesis. J Control Release. 106:224–234.
   PubMed Web of Science ®Google Scholar
• Klajnert B. Bryszewska M. 2000. Dendrimers: properties and applications. Acta Biochim Polonica. 48:199–208.
   Web of Science ®Google Scholar
• Kneuer C, Sameti M, Bakowsky U, Schiestel T, Schirra H, Schmidt H, Lehr CM. 2000a. A nonviral DNA delivery system based on surface modified silica-nanoparticles can efficiently transfect cells in vitro. Bioconjug Chem. 11:926–932.
   PubMed Web of Science ®Google Scholar
• Kneuer C, Sameti M, Haltner EG, Schiestel T, Schirra H, Schmidt H, Lehr CM. 2000b. Silica nanoparticles modified with aminosilanes as carriers for plasmid DNA. Int J Pharm. 196:257–261.
   PubMed Web of Science ®Google Scholar
• Knowles MR, Hohneker KW, Zhou Z, Olsen JC, Noah TL, Hu PC, et al. 1995. A controlled study of adenoviral-vector–mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Engl J Med. 333:823–831.
   PubMed Web of Science ®Google Scholar
• Krebs MD, Salter E, Chen E, Sutter KA, Alsberg E. 2010. Calcium phosphate‐DNA nanoparticle gene delivery from alginate hydrogels induces in vivo osteogenesis. J Biomed Mater Res Part A. 92:1131–1138.
   PubMed Web of Science ®Google Scholar
• Lai SK, Wang Y-Y, Hanes J. 2009. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev. 61:158–171.
   PubMed Web of Science ®Google Scholar
• Ledley FD. 1996. Pharmaceutical approach to somatic gene therapy. Pharm Res. 13:1595–1614.
   PubMed Web of Science ®Google Scholar
• Lee M, Kim SW. 2005. Polyethylene glycol-conjugated copolymers for plasmid DNA delivery. Pharm Res. 22:1–10.
   PubMed Web of Science ®Google Scholar
• Lucas P, Milroy DA, Thomas BJ, Moss SH, Pouton CW. 1999. Pharmaceutical and biological properties of poly (amino acid)/DNA polyplexes. J Drug Target. 7:143–156.
   PubMed Web of Science ®Google Scholar
• Ma Y, Kolotuchin SV, Zimmerman SC. 2002. Supramolecular Polymer Chemistry: Self-Assembling Dendrimers Using the DDA⊙ AAD (GC-like) Hydrogen Bonding Motif. J Am Chem Soc. 124: 13757–13769.
   PubMed Web of Science ®Google Scholar
• Malafaya PB, Silva GA, Reis RL. 2007. Natural–origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. Adv Drug Deliv Rev. 59:207–233.
   PubMed Web of Science ®Google Scholar
• McIntosh CM, Esposito EA III3rd, Boal AK, Simard JM, Martin CT, Rotello VM. 2001. Inhibition of DNA transcription using cationic mixed monolayer protected gold clusters. J Am Chem Soc. 123: 7626–7629.
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mäder K. 2001. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 47: 165–196.
   PubMed Web of Science ®Google Scholar
• Melo LG, Pachori AS, Kong D, Gnecchi M, Wang K, Pratt RE, Dzau VJ. 2004. Gene and cell-based therapies for heart disease. FASEB J. 18:648–663.
   PubMed Web of Science ®Google Scholar
• Merdan T, Kunath K, Fischer D, Kopecek J, Kissel T. 2002. Intracellular processing of poly (ethylene imine)/ribozyme complexes can be observed in living cells by using confocal laser scanning microscopy and inhibitor experiments. Pharm Res. 19:140–146.
   PubMed Web of Science ®Google Scholar
• Mirkin CA, Letsinger RL, Mucic RC, Storhoff JJ. 1996. A DNA-based method for rationally assembling nanoparticles into macroscopic materials. Nature. 382:607–609.
   PubMed Web of Science ®Google Scholar
• Mourey TH, Turner SR, Rubinstein M, Frechet JMJ, Hawker CJ, Wooley KL. 1992. Unique behavior of dendritic macromolecules: intrinsic viscosity of polyether dendrimers. Macromolecules. 25:2401–2406.
   Web of Science ®Google Scholar
• Müller R, Maaen S, Weyhers H, Specht F, Lucks JS. 1996. Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles. Int J Pharm. 138:85–94.
   Web of Science ®Google Scholar
• Müller RH, Mäder K, Gohla S. 2000. Solid lipid nanoparticles (SLN) for controlled drug delivery–a review of the state of the art. Eur J Pharm Biopharm. 50:161–177.
   PubMed Web of Science ®Google Scholar
• Ogris M, Brunner S, Schüller S, Kircheis R, Wagner E. 1999. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 6:595–605.
   PubMed Web of Science ®Google Scholar
• Panyam J, Labhasetwar V. 2003. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev. 55:329–347.
   PubMed Web of Science ®Google Scholar
• Park TG, Jeong JH, Kim SW. 2006. Current status of polymeric gene delivery systems. Adv Drug Deliv Rev. 58:467–486.
   PubMed Web of Science ®Google Scholar
• Partridge KA, Oreffo RO. 2004. Gene delivery in bone tissue engineering: progress and prospects using viral and nonviral strategies. Tissue Eng. 10:295–307.
   PubMedGoogle Scholar
• Petersen H, Fechner PM, Martin AL, Kunath K, Stolnik S, Roberts CJ. 2002. Polyethylenimine-graft-poly (ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. Bioconjug Chem. 13:845–854.
   PubMed Web of Science ®Google Scholar
• Phillips SC. 1995. Receptor-mediated DNA delivery approaches to human gene therapy. Biologicals. 23:13–16.
   PubMed Web of Science ®Google Scholar
• Pissuwan D, Niidome T, Cortie MB. 2011. The forthcoming applications of gold nanoparticles in drug and gene delivery systems. J Control Release. 149:65–71.
   PubMed Web of Science ®Google Scholar
• Rosenberg SA, Aebersold P, Cornetta K, Kasid A, Morgan RA, Moen R, et al. 1990. Gene transfer into humans—immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med. 323: 570–578.
   PubMed Web of Science ®Google Scholar
• Rosi NL, Giljohann DA, Thaxton CS, Lytton-Jean AK, Han MS, Mirkin CA. 2006. Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science. 312:1027–1030.
   PubMed Web of Science ®Google Scholar
• Sandhu KK, McIntosh CM, Simard JM, Smith SW, Rotello VM. 2002. Gold nanoparticle-mediated transfection of mammalian cells. Bioconjug Chem. 13:3–6.
   PubMed Web of Science ®Google Scholar
• Schaffert D, Wagner E. 2008. Gene therapy progress and prospects: synthetic polymer-based systems. Gene Ther. 15:1131–1138.
   PubMed Web of Science ®Google Scholar
• Schmidt P. 1997. Pharmazeutische Technologie: Moderne Arzneiformen. Lehrbuch für Studierende der Pharmazie, Nachschlagewerk für Apotheker in Offizin, Krankenhaus und Forschung. Von RH Müller und GE Hildebrand. 348 Seiten, 117 Abbildungen, 57 Tabellen. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart 1997. DM 64,‐, ISBN 3‐8047‐1504‐4. Pharm Unserer Zeit. 26:323–323.
   Google Scholar
• Schwarz C, Mehnert W, Lucks JS, Müller RH. 1994. Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. J Control Release. 30: 83–96.
   Web of Science ®Google Scholar
• Smith A. 1986. Evaluation of poly (lactic acid) as a biodegradable drug delivery system for parenteral administration. Int J Pharm. 30: 215–220.
   Web of Science ®Google Scholar
• Suh W, Han SO, Yu L, Kim SW. 2002. An angiogenic, endothelial-cell-targeted polymeric gene carrier. Mol Ther. 6:664–672.
   PubMed Web of Science ®Google Scholar
• Thomas M, Klibanov AM. 2003. Conjugation to gold nanoparticles enhances polyethylenimine's transfer of plasmid DNA into mammalian cells. Proc Natl Acad Sci. 100:9138–9143.
   PubMed Web of Science ®Google Scholar
• Westesen K, Siekmann B. 1997. Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles. Int J Pharm. 151:35–45.
   Web of Science ®Google Scholar
• Wightman L, Kircheis R, Rössler V, Carotta S, Ruzicka R, Kursa M, Wagner E. 2001. Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J Gene Med. 3:362–372.
   PubMed Web of Science ®Google Scholar
• Wissing S, Kayser O, Müller R. 2004. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev. 56:1257–1272.
   PubMed Web of Science ®Google Scholar
• Wivel NA, Wilson JM. 1998. Methods of gene delivery. Hematol Oncol Clin North Am. 12:483–501.
   PubMed Web of Science ®Google Scholar
• Wolfert MA, Dash PR, Nazarova O, Oupicky D, Seymour LW, Smart S, et al. 1999. Polyelectrolyte vectors for gene delivery: influence of cationic polymer on biophysical properties of complexes formed with DNA. Bioconjug Chem. 10:993–1004.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Qian H, Young WG, Bartold PM. 2003. Tissue engineering for bone regeneration using differentiated alveolar bone cells in collagen scaffolds. Tissue Eng. 9:1167–1177.
   PubMedGoogle Scholar
• Yang S, Leong KF, Du Z, Chua CK. 2001. The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Eng. 7:679–689.
   Web of Science ®Google Scholar
• Yin Y, Alivisatos AP. 2004. Colloidal nanocrystal synthesis and the organic–inorganic interface. Nature. 437:664–670.
   Web of Science ®Google Scholar
• zur Mühlen A, Schwarz C, Mehnert W. 1998. Solid lipid nanoparticles (SLN) for controlled drug delivery–drug release and release mechanism. Eur J Pharm Biopharm. 45:149–155.
   PubMed Web of Science ®Google Scholar